Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
This project aims to develop a point-of-care test for neonatal sepsis in a simple lateral flow test format.
It will provide frontline healthcare workers with the ability to provide initial diagnosis and timely, effective treatment for millions of newborns in resource-constrained settings.
It should also improve management of sepsis in adults and in the developed world.
Neonatal sepsis specifically refers to the presence in a newborn baby of a bacterial blood stream infection (BSI) (such as meningitis, pneumonia, pyelonephritis, or gastroenteritis) in the setting of fever.
Neonatal sepsis continues to be a common and significant health care burden, especially in very-low-birth-weight infants. In neonates, sepsis is difficult to diagnose clinically and often they may be relatively asymptomatic.
For any general enquiries relating to this project, please contact:
Deputy Director (Partnerships), Burnet Institute; Chief Scientific Officer, Burnet Diagnostics Initiative
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2022 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
